Profile
BLCO ISRG BDXA BDX RMD ALC
Company Name Bausch + Lomb Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $5.19B $160.63B $55.91B $53.65B $41.34B $37.85B
Employees 13.50K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Brenton L. Saunders Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
BLCO ISRG BDXA BDX RMD ALC
Quant Rating Score 2 3 5 3 4 3
Quant Rating Sell Neutral Strong Buy Neutral Buy Neutral
Trading
BLCO ISRG BDXA BDX RMD ALC
Last Close $14.71 $448.09 $59.24 $193.93 $282.35 $76.55
High 52 $20.93 $610.45 $59.24 $249.08 $293.73 $98.3
Low 52 $10.91 $433.48 $59.24 $165.15 $204.58 $73.24
Price vs. 52 Week High -29.72 % -26.6 % 0 % -22.14 % -3.87 % -22.13 %
Price vs. 52 Week Low 34.83 % 3.37 % 0 % 17.43 % 38.01 % 4.52 %
Total Return
BLCO ISRG BDXA BDX RMD ALC
1 Month Return -3.86 % -4.16 % 0 % 1.81 % 1.12 % -2.97 %
3 Month Return 4.7 % -15.1 % 0 % 10.5 % 10.4 % -11.99 %
6 Month Return 17.4 % -14.29 % 0 % -7.37 % 30.43 % -14.87 %
9 Month Return -18.64 % -17.63 % 0 % -17.28 % 19.55 % -8.55 %
YTD Return -18.55 % -14.15 % 0 % -14.52 % 23.46 % -9.82 %
1 Year Return -22 % -8.62 % 0 % -18.59 % 19.11 % -20.62 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BLCO ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.17 % 2.22 % 0.78 % 0.44 %
Dividend Paid and Capex Coverage Ration (TTM) 0.53 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Growth
BLCO ISRG BDXA BDX RMD ALC
Asset Growth 0.2 % 8.54 %
Gross Profit Growth 16.57 % 11.69 %
Revenue Growth 15.15 % 4.16 %
Revenue 3 Year 26.15 % 5.3 %
Revenue 5 Year 25.72 % 8.72 %
Revenue 10 Year 29.59 % 59.37 %
EBIT Growth 52.14 % 19.82 %
Net Income Growth -21.92 % 14.89 %
Net Income 3 Yeari Growth Per Share -273.28 % -18.63 %
Net Income 5 Yeari Growth Per Share -205.83 % 28.82 %
Net Income 10 Yeari Growth Per Share -144.42 % -4.02 %
Operating Income Growth 24.62 % 13.55 %
Operating Cash Flow Growth (CFG) 1464.71 % 27.07 %
Operating 3 Year CFG -73.56 % -18.4 %
Operating 5 Year CFG -71.11 % 6.25 %
Operating 10 Year CFG -69.75 % 45.28 %
EPS Growth -21.62 % 18.31 %
EPS Diluted Growth -21.62 % 18.62 %
Book Value Per Share -5.78 % -0.85 %
Share Holder 3 Year Equity Growth Per Share -30.97 % 9.16 %
Share Holder 5 Year Equity Growth Per Share -35.34 % 14.4 %
Share Holder 10 Year Equity Growth Per Share - 241.78 %
Dividend Per Share Growth - -2.44 %
Dividend 3 Year Growth Per Share - 4.79 %
Dividend 5 Year Growth Per Share - 4.14 %
Dividend 10 Year Growth Per Share - 74.3 %
Debt Growth 4.87 % 31.74 %
Free Cash Flow Growth 70.2 % 45.25 %
Updated On 31 Dec 2024 30 Sep 2024
Profitability
BLCO ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 59.73 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM -2.9 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM -6.2 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 0.3 % 14.26 % 5.78 % 5.78 % 23.55 % 4.98 %
Net Income Per EBT TTM 101.52 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM -1097.22 % 113.2 % 70.86 % 70.86 % 99.54 % 86.96 %
EBIT Per Revenue TTM 0.74 % 28.8 % 12.63 % 12.63 % 32.75 % 14.38 %
Cash Flow To Debt Ratio TTM 3.75 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 4.49 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 4.55 11.43 1.85 1.85 7.52 5.03
Inventory Turnover TTM 1.94 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 290.89 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 35.33 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM 0.53 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -0.47 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 76.9 % 1485.77 % 262.85 % 262.85 % 825.72 % 284.33 %
Operating Cash Flow Sales Ratio TTM 3.81 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM -88.71 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM 3.75 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -31.44 80.54 21.58 21.04 24.92 23.68
Price To Operating Cash Flows Ratio TTM 27.88 56.84 16.99 16.57 23.61 18.38
Price Cash Flow Ratio TTM 27.88 56.84 16.99 16.57 23.61 18.38
Income Statement (TTM)
BLCO ISRG BDXA BDX RMD ALC
Revenue $4.77B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $2.92B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 61.14% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $0.61B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $-0.32B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted -0.9 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
BLCO ISRG BDXA BDX RMD ALC
Long Term Debt $4.86B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $6.93B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $6.54B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0.02B $7.05B $0.45B $0.45B $0.09B $0.91B
Total Debt $4.78B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $13.47B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
BLCO ISRG BDXA BDX RMD ALC
Net Income $-0.31B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $-0.15B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $0.23B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0.29B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.53
ANGO AngioDynamics, Inc. 11.14
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 130.62
ATRC AtriCure, Inc. 36.47
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 31.73
BAX Baxter International Inc. 22.49
BDX Becton, Dickinson and Company 189.15
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLFS BioLife Solutions, Inc. 27.44
COO The Cooper Companies, Inc. 69.76
DXR Daxor Corporation 12.85
EKSO Ekso Bionics Holdings, Inc. 5.33
FEMY Femasys Inc. 0.6535
GCTK GlucoTrack, Inc. 8.21
ETFs With Exposure to BLCO
Ticker ETF Name Weight Percentage Price
FPX First Trust US Equity Opportunities ETF 0.43 167.02
PDN Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.03 40.925
CZA Invesco Zacks Mid-Cap ETF 0.324 108.985
PWC Invesco Dynamic Market ETF 0.353 37.8843
XCV.TO iShares Canadian Value Index ETF 0.07374 48
BBCA JPMorgan BetaBuilders Canada ETF 0.04 87.09
BKMC BNY Mellon US Mid Cap Core Equity ETF 0.02 108.48
BKSE BNY Mellon US Small Cap Core Equity ETF 0.03 110.3
BMED BlackRock Future Health ETF 0.38821 27.9
GUSA Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0 58.06
DFIC Dimensional International Core Equity 2 ETF 0.00036101 32.805
AGED.L iShares Ageing Population UCITS ETF 0.05835 9.1175
DFSI Dimensional International Sustainability Core 1 ETF 0.00534105 41.05
AGES.L iShares Ageing Population UCITS ETF 0.05835 686.125
2B77.DE iShares Ageing Population UCITS ETF 0.05835 7.903
FSYD Fidelity Sustainable High Yield ETF 0.01 48.31
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00175346 31.449
QWST Harbor ETF Trust - Harbor Small Cap Explorer ETF 0.5 32.0152
Unlock